Gene regulation by antisense transcription: A focus on neurological and cancer diseases


Najafi S., Tan S. C. , Raee P., Rahmati Y., Asemani Y., Lee E. H. C. , ...More

BIOMEDICINE & PHARMACOTHERAPY, vol.145, 2022 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Review
  • Volume: 145
  • Publication Date: 2022
  • Doi Number: 10.1016/j.biopha.2021.112265
  • Title of Journal : BIOMEDICINE & PHARMACOTHERAPY
  • Keywords: Antisense RNA, Cancer, Long non-coding RNA, Neurodegenerative diseases, Therapeutic targets, LONG NONCODING RNA, NATURAL ANTISENSE, ALZHEIMERS-DISEASE, SIGNALING PATHWAY, POOR-PROGNOSIS, BREAST-CANCER, LNCRNA HOTAIR, CHROMATIN MODIFICATION, NEUROTROPHIC FACTOR, PARKINSONS-DISEASE

Abstract

Advances in high-throughput sequencing over the past decades have led to the identification of thousands of non coding RNAs (ncRNAs), which play a major role in regulating gene expression. One emerging class of ncRNAs is the natural antisense transcripts (NATs), the RNA molecules transcribed from the opposite strand of a protein coding gene locus. NATs are known to concordantly and discordantly regulate gene expression in both cis and trans manners at the transcriptional, post-transcriptional, translational, and epigenetic levels. Aberrant expression of NATs can therefore cause dysregulation in many biological pathways and has been observed in many genetic diseases. This review outlines the involvements and mechanisms of NATs in the pathogenesis of various diseases, with a special emphasis on neurodegenerative diseases and cancer. We also summarize recent findings on NAT knockdown and/or overexpression experiments and discuss the potential of NATs as promising targets for future gene therapies.